You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-PLL

Showing 26 - 50 of 8,011
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Orca-T
  • Standard-of-Care
  • Duarte, California
  • +13 more
Jan 25, 2023

Hematologic Malignancies Trial in Zhengzhou (RD13-02 cell infusion)

Recruiting
  • Hematologic Malignancies
  • RD13-02 cell infusion
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jun 26, 2023

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD19/CD22-bispecific CAR-T cells
  • Beijing, Beijing, China
    Liang Wang
Oct 7, 2023

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Hefei (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Jun 5, 2023

Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

Not yet recruiting
  • Non-hodgkin Lymphoma
  • +9 more
  • CD79b-19 CAR T cells
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 6, 2023

Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)

Recruiting
  • Brain Gliomas
  • Allogenic B7H3 CAR-γδT cell
  • Suzhou, Jiangsu, China
    Dushu Lake Hospital Affiliated to Soochow University
Aug 25, 2023

Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

Active, not recruiting
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • gene-modified T cells targeted
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

Metastatic Breast Cancer Trial in Rome (HER2-D is the use of a non-invasive liquid biopsy method to non-invasively and

Recruiting
  • Metastatic Breast Cancer
  • HER2-D is the use of a non-invasive liquid biopsy method to non-invasively and objectively assess HER2 status at recruitment
  • Rome, Italy
    Fondazione Policlinico A. Gemelli - IRCCS
Jun 22, 2023

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Xuzhou, Jiangsu, China
    Affiliated hospital of Xuzhou medical college
Jun 7, 2023

T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,

Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • +3 more
  • Universal CD7-specific CAR gene-engineered T cells
  • Beijing, Beijing, China
  • +2 more
Aug 17, 2023

Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

Recruiting
  • Extranodal NK T Cell Lymphoma
  • NK-Cell Leukemia
  • Anti-CD56 CAR T
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Jul 10, 2023

Determining the Mechanisms of Loss of CAR T Cell Persistence

Not yet recruiting
  • Acute Lymphoblastic Leukemia With Failed Remission
  • +4 more
    • (no location specified)
    Mar 29, 2023

    Sinus Lifting Trial in Alexandria (T-PRF alone, T-PRF/Xenograft)

    Completed
    • Sinus Lifting
    • T-PRF alone
    • T-PRF/Xenograft
    • Alexandria, Egypt
      Outpatient Clinic of Oral and Maxillofacial Surgery Department,
    Nov 11, 2023

    CX3CR1+T Cell Predict Immunotherapy Efficacy

    Recruiting
    • Non-small Cell Lung Cancer
    • PD-1 inhibitor based immunotherapy
    • Changsha, Hunan, China
    • +1 more
    Sep 19, 2023

    TINO: T Cells in the Nose of Older Adults

    Recruiting
    • Respiratory Tract Infections
    • Aging
      • Leiden, Zuid Holland, Netherlands
        Leiden University Medical Center
      Sep 8, 2023

      Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • BTK inhibitor
      • PD-1 inhibitor
      • Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
      May 20, 2023

      T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

      Recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • Hangzhou, Zhejiang, China
        The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
      Aug 7, 2023

      Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

      Not yet recruiting
      • Prostate Carcinoma
      • +3 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Oct 17, 2023

      Head Neck Cancer, Relapse, Recurrent Trial in Chapel Hill (Cyclophosphamide, Fludarabine, Cell Therapy)

      Not yet recruiting
      • Head and Neck Cancer
      • +3 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Oct 18, 2023

      CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

      Not yet recruiting
      • Lymphoma
      • Chimeric Antigen Receptor
      • (no location specified)
      Oct 24, 2023

      Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Aldesleukin
      • +12 more
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Aug 9, 2023

      Chronic Hepatitis B Trial in Beijing (TCR-T)

      Active, not recruiting
      • Chronic Hepatitis B
      • TCR-T
      • Beijing, China
        The Fifth Medical Center of PLA General Hospital
      Jun 13, 2023

      Metastatic Solid Tumor Trial (TAC01-CLDN18.2)

      Not yet recruiting
      • Metastatic Solid Tumor
      • TAC01-CLDN18.2
      • (no location specified)
      May 8, 2023

      Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • +5 more
      • La Jolla, California
      • +7 more
      Aug 25, 2023

      Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)

      Not yet recruiting
      • Recurrent Diffuse Large B-Cell Lymphoma
      • Refractory Diffuse Large B-Cell Lymphoma
      • Biospecimen Collection
      • +6 more
      • Duarte, California
        City of Hope Medical Center
      Mar 24, 2023